Sanofi SA (SAN) - Total Liabilities

Latest as of December 2025: €55.10 Billion EUR ≈ $64.41 Billion USD

Based on the latest financial reports, Sanofi SA (SAN) has total liabilities worth €55.10 Billion EUR (≈ $64.41 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Sanofi SA to track the company's year-over-year net asset growth rate.

Sanofi SA - Total Liabilities Trend (1999–2025)

This chart illustrates how Sanofi SA's total liabilities have evolved over time, based on quarterly financial data. See SAN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Sanofi SA Competitors by Total Liabilities

The table below lists competitors of Sanofi SA ranked by their total liabilities.

Company Country Total Liabilities
Newmont Corporation
AU:NEM
Australia AU$22.57 Billion
Marriott International Inc
NASDAQ:MAR
USA $31.95 Billion
Brookfield Corporation
TO:BN
Canada CA$352.13 Billion
Prosus N.V.
AS:PRX
Netherlands €24.17 Billion
Quanta Services Inc
NYSE:PWR
USA $16.60 Billion
Mizuho Financial Group Inc
F:MZ8A
Germany €286.31 Trillion
McKesson Corporation
NYSE:MCK
USA $83.16 Billion
Enel SpA
F:ENLA
Germany €131.85 Billion

Liability Composition Analysis (1999–2025)

This chart breaks down Sanofi SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SAN market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.09 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.27 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.77 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sanofi SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sanofi SA (1999–2025)

The table below shows the annual total liabilities of Sanofi SA from 1999 to 2025.

Year Total Liabilities Change
2025-12-31 €55.10 Billion
≈ $64.41 Billion
+0.28%
2024-12-31 €54.94 Billion
≈ $64.23 Billion
+5.43%
2023-12-31 €52.11 Billion
≈ $60.92 Billion
+1.05%
2022-12-31 €51.57 Billion
≈ $60.29 Billion
+0.70%
2021-12-31 €51.21 Billion
≈ $59.87 Billion
+0.10%
2020-12-31 €51.16 Billion
≈ $59.81 Billion
-4.60%
2019-12-31 €53.63 Billion
≈ $62.70 Billion
+2.40%
2018-12-31 €52.37 Billion
≈ $61.23 Billion
+25.98%
2017-12-31 €41.57 Billion
≈ $48.60 Billion
-11.45%
2016-12-31 €46.95 Billion
≈ $54.89 Billion
+6.43%
2015-12-31 €44.11 Billion
≈ $51.57 Billion
+7.26%
2014-12-31 €41.12 Billion
≈ $48.08 Billion
+5.39%
2013-12-31 €39.02 Billion
≈ $45.62 Billion
-9.13%
2012-12-31 €42.94 Billion
≈ $50.20 Billion
-3.05%
2011-12-31 €44.30 Billion
≈ $51.79 Billion
+38.53%
2010-12-31 €31.98 Billion
≈ $37.38 Billion
+1.18%
2009-12-31 €31.60 Billion
≈ $36.95 Billion
+17.41%
2008-12-31 €26.92 Billion
≈ $31.47 Billion
+10.84%
2007-12-31 €24.28 Billion
≈ $28.39 Billion
-14.65%
2006-12-31 €28.45 Billion
≈ $33.26 Billion
-29.97%
2005-12-31 €40.63 Billion
≈ $47.50 Billion
-7.42%
2004-12-31 €43.88 Billion
≈ $51.31 Billion
+1190.09%
2003-12-31 €3.40 Billion
≈ $3.98 Billion
-0.24%
2002-12-31 €3.41 Billion
≈ $3.99 Billion
-18.39%
2001-12-31 €4.18 Billion
≈ $4.88 Billion
+18.93%
2000-12-31 €3.51 Billion
≈ $4.11 Billion
+9.34%
1999-12-31 €3.21 Billion
≈ $3.76 Billion
--

About Sanofi SA

PA:SAN France Drug Manufacturers - General
Market Cap
$108.59 Billion
€92.88 Billion EUR
Market Cap Rank
#262 Global
#10 in France
Share Price
€76.91
Change (1 day)
-0.56%
52-Week Range
€72.49 - €90.44
All Time High
€109.62
About

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting aga… Read more